Complement C3 as therapeutic target in diabetic nephropathy by bioinformatics analysis
Preprint
- 29 February 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Various public platforms have contained extensive data for deeper bioinformatics analysis. The pathogenesis of diabetic nephropathy is always a hot topic and the underlying molecular events are not completely clear. Methods: Differential expression analysis and weighted correlation network analysis (WGCNA) were applied to screen meaningful gene in GSE30529. The combined result was used for gene ontology (GO) annotation and KEGG pathway enrichment analysis. STRING was used for protein-protein interaction (PPI) network construction and Cytoscape software was used for hub gene identification. Gene methylation profile GSE121820 and miRNA profile GSE51674 were also acquired to perform multi-omics analysis. Clinical features were obtained form Nephroseq and potential drugs were identified by CMap. Results: 345 genes were obtained form GSE30529 after differential expression analysis and WGCNA. GO analysis mainly included neutrophil activation, regulation of immune effector process, positive regulation of cytokine production and neutrophil mediated immunity. KEGG pathway analysis mostly included phagosome, complement and coagulation cascades, cell adhesion molecules and AGE-RAGE signaling pathway in diabetic complications. 16 down regulated miRNAs were obtained from GSE57674 to construct miRNA-mRNA network. Top 20 genes were discerned from PPI network and there were DNA methylation differences in 15 genes among them. Correlation analysis showed SYK, CXCL1, LYN, VWF, ANXA1, C3, HLA-E, RHOA, SERPING1, EGF and KNG1 may involved in DN. 10 small molecule compounds have been identified as potential therapeutic drugs. Conclusion: We screened 11 target genes and suggested C3 may serve as a therapeutic target in diabetic nephropathy.Keywords
All Related Versions
This publication has 50 references indexed in Scilit:
- Complement deposition on renal histopathology of patients with diabetic nephropathyDiabetes & Metabolism, 2019
- Complement activation in patients with diabetic nephropathyDiabetes & Metabolism, 2019
- Serum levels of immunoglobulin G and complement 3 differentiate non-diabetic renal disease from diabetic nephropathy in patients with type 2 diabetes mellitusActa Diabetologica, 2019
- Diabetic kidney disease: A systematic review on the role of epigenetics as diagnostic and prognostic markerDiabetes/Metabolism Research and Reviews, 2019
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045Diabetes Research and Clinical Practice, 2018
- A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 ProfilesCell, 2017
- RETRACTED ARTICLE: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetesDiabetologia, 2017
- A more tubulocentric view of diabetic kidney diseaseJournal Of Nephrology, 2017
- Sinomenine alleviates high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the activation of RhoA/ROCK signaling pathwayBiochemical and Biophysical Research Communications, 2016
- Binding of mannose‐binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetesDiabetes/Metabolism Research and Reviews, 2010